Embracing model-based designs for dose-finding trials
Sharon Love(Nuffield Orthopaedic Centre), Victoria Cornelius(Imperial College London), Louise Caffrey(Trinity College Dublin), James Spicer(King's College London), Sally Clive(Western General Hospital), Chris Harbron(Roche (United Kingdom)), Christopher McKevitt(King's College London), Sarah Brown(University of Leeds), Charles Craddock(University Hospitals Birmingham NHS Foundation Trust), Birgit Gaschler‐Markefski(Boehringer Ingelheim (Germany)), Christopher J. Weir(University of Edinburgh), James Matcham(Goethe University Frankfurt), Christina Yap(Institute of Cancer Research)
Cited by 68
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
|New England Journal of Medicine|2020|1.2k
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
|Nature Medicine|2020|1.2k